33 studies found for:    " November 01, 2008":" December 01, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 01, 2008":" December 01, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
Conditions: HIV Infection;   HIV Seronegativity
Intervention:
2 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
3 Completed
Has Results
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Conditions: Cardiovascular Disease;   HIV Infection
Interventions: Drug: Lovaza;   Drug: Placebo
4 Recruiting Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Conditions: HIV Infections;   AIDS;   Opportunistic Infections
Intervention:
5 Active, not recruiting Micronutrients and Antioxidants in HIV Infection
Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants;   Dietary Supplement: Multivitamins and minerals
6 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
7 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
8 Unknown  Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
9 Completed A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence
Condition: HIV Infection
Intervention: Other: MEMS cap monitoring
10 Completed Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans
Conditions: Binge Drinking;   Alcohol Abuse;   Alcohol Dependence;   HIV Infections
Interventions: Behavioral: HIV support group;   Behavioral: CBT
11 Completed Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Condition: HIV Infections
Interventions: Drug: Zoledronic acid;   Behavioral: Lifestyle modifications
12 Active, not recruiting
Has Results
An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
13 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Biological: Gardisil;   Behavioral: Survey
14 Completed Healthy Teen Girls: HIV Risk Reduction
Condition: HIV-infection/Aids
Intervention: Behavioral: Cognitive-behavioral HIV/STD risk reduction
15 Completed A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Conditions: Lymphoma, AIDS Related;   HIV Infections
Intervention: Drug: R-EPOCH and cART
16 Recruiting Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Condition: Acute HIV Infection
Intervention:
17 Withdrawn Immune Responses in Patients Treated With Raltegravir
Condition: HIV Infections
Intervention: Biological: Various vaccines
18 Completed Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
Condition: HIV
Intervention: Biological: Dendritic Cell Vaccine
19 Completed Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
Conditions: Buprenorphine;   HIV;   Drug Abuse;   Drug Addiction;   Drug Dependence;   Drug Use Disorders;   Drug Use Disorder;   Substance Abuse;   Opiate Addiction;   Substance-related Disorders
Interventions: Other: Services will be provided at one site;   Other: Services remain dispersed; i.e., not centralized to one-location or provider.
20 Completed Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults
Conditions: Malaria;   HIV
Interventions: Drug: Artemether/Lumefantrine;   Drug: Artemether/ lumefantrine

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years